Continue reading this on our app for a better experience

Open in App
Home News Medtech

Thomson Medical Group subsidiary partners healthtech startup to manage myopia in Asia

Felicia Tan
Felicia Tan • 1 min read
Thomson Medical Group subsidiary partners healthtech startup to manage myopia in Asia
The partnership will grant Thomson X an option to subscribe to an equity stake in Plano.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Thomson X, a wholly-owned subsidiary of Thomson Medical Group, has inked a strategic partnership with Plano, a Singapore-based healthtech startup.

The collaboration will leverage on the strengths of Thomson X and Plano to address and manage myopia through technological solutions, which Plano specialises in.

Myopia is said to be growing into one of the biggest public health challenges in the world, affecting 2.6 billion globally.

The partnership will grant Thomson X an option to subscribe to an equity stake in Plano, which can be exercised in three tranches over a six-year period based on certain conditions.

If all three tranches are exercised, Thomson X will hold a minority stake in Plano.

Shares in Thomson closed 0.1 cent lower or 2.0% down at 4.8 cents on Feb 5.

×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.